Roundtable Discussion: How Can we Best Apply AI for Streamlined Drug Discovery in CKD?
- Explore how AI and machine learning are being applied to target identification, protein engineering, and biomarker discovery in CKD, with a focus on DKD
- Examine case studies and strategies from different labs and companies to understand the practical implementation and evolving performance of AI tools
- Discuss the integration of AI across preclinical and clinical stages to accelerate precision nephrology research and development
- Consider collaborative approaches and future frameworks, including shared strategies or white papers, to advance AI use in kidney disease drug discovery and beyond